You are here
Neurogenesis and neurotoxicity: Pt 2 of roundtable with Dr Henry Nasrallah, Dr Jim van Os, and Dr Diana Perkins at ECNP 2014.
In part 2 of this round table, the group suggest that a better understanding of neurogenesis could open up novel pathways in schizophrenia treatment. There is hope that the future is going to elucidate specific pathoetiologies and identify specific treatments. Concerns are raised over treatments that are potentially neurotoxic over a long period of time, compared to treatments that potentially stimulate neurogenesis. They explore the role of microglial activation in schizophrenia and the need to further understand brain plasticity in order to capitalise on it when developing treatments.
- In the area of neurogenesis, neuroprotection and neurotoxicity, are new promising therapies expected in the future?
- When you talk about neurotoxicity and neurogenesis at sort of mechanisms are you referring to?
- Is there a link between inflammation mechanisms and immunoregulation with schizophrenia